Matches a patient's biomarker profile to the drug combinations most likely to produce an effective response.
Consented intake · your records travel with you · nothing moves without your sign-off
CureMatch focuses on biomarker-drug matching for combination therapies. Starting from the disease profile in a patient's test data, it recommends the treatment options judged most likely to bring an effective response. It is for patients and care teams who want treatment ideas informed by broad global thinking, with a prediction of how well each option fits this specific cancer.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how CureMatch (drug combinations) handles billing.
We don't have confirmed insurance details for CureMatch (drug combinations) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in CureMatch's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Identify the best treatment ideas using the best global thinking, predict best treatment response
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.